| BCS | Biopharmaceutical classification system |
| PC | Phenolic compound |
| P-gp | P-glycoprotein |
| SGLT1 | Sodium-glucose transporter |
| Nrf-2 | Nuclear factor (erythroid-derived 2)-like 2 |
| LogP | Partition coefficient logarithm P |
| RB | Rotatable bonds |
| HBA/HBD | Hydrogen-bonding acceptor/donor |
| FA | Ferulic acid |
| FDA | Food and Drug Administration |
| AUC | Area under the curve |
| LogD | Distribution coefficient logarithm D |
| QSAR | Quantitative structure-activity relationship |
| RP-HPLC | Reverse phase high-performance liquid chromatography |
| USFDA | United States Food and Drug Administration |
| WHO | World Health Organization |
| N/A | Not available |
| S | Solubility |
| API | Active pharmaceutical ingredient |
| D | Highest dose |
| D/S | Highest dose and solubility ratio |
| EMA | European Medicines Agency |
| IR | Immediate release |
| EML | List of Essential Medicines |
| SDAD | Single dietary abundant dose |
| ADI | Acceptable daily intake |
| NOAEL | No observed adverse effect level |